BociMed

China
Shaxi, Fujian, China

Company profile

BociMed company profile

BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,

Business identity

Contact email
[email protected]
Phone number
68861631, 68861632
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Founded
2012-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$14.6M
Last funding
Series B / $14.6M / 2023-02-15
Last equity funding
Series B / $14.6M
Investors
8
Lead investors
3
Articles
8

Founders and investors

Lead investors

Guoxin InvestmentRichen CapitalShanghai STVC Group

Investors

Guoxin InvestmentRichen CapitalShanghai STVC GroupShanghai Zhangjiang Haocheng Venture CapitalZhangjiang Torch Venture Capital Co